STVN — Stevanato Group S.p.A.

NYSE · Health Care · Health Care Equipment & Supplies · CIK 1849853 · Italy
Last close
$19.85
Market Cap
$986.74M
52W High
$20.99
52W Low
$16.27
ADV30
304,487
Next earnings
2026-08-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 273,574,000 75,178,000 38,737,000 28,029,000 2,583,821,000 111,670,000 1,052,995,000
Dec 2025 346,482,000 106,899,000 70,084,000 47,555,000 2,543,974,000 130,603,000 1,057,453,000
Sep 2025 303,167,000 88,500,000 52,721,000 36,064,000 2,414,007,000 113,333,000 976,721,000
Jun 2025 280,000,000 78,600,000 41,400,000 29,700,000 2,351,100,000 94,200,000 953,200,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$261,728,000
Investing CF
$-272,608,000
Financing CF
$32,881,000
CapEx
$-273,964,000
Dividends Paid
$-14,457,000
Buybacks
EPS Diluted TTM
$0.51
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$1,019,614,000
Inventory
$294,360,000
Receivables
$506,659,000
ST Investments
$1,064,000
EBIT TTM
$209,266,000
Pretax Income TTM
$193,228,000
Interest Exp TTM
$16,038,000
Analysts
8

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,203,260,032
EBITDA
$288,579,008
Free Cash Flow
$-57,059,124
Enterprise Value
$5,757,467,136
Total Cash
$112,276,000
Total Debt
$450,584,000
Shares Out
49,709,718
Trailing EPS
$0.59
Book Value
$6.39
ROE
9.6%
ROA
5.3%
Div Yield
0.31%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,186,282,000 198,801,000 139,839,000 2,543,974,000 1,057,453,000 286,077,000
Dec 2024 1,104,036,000 161,142,000 117,778,000 2,328,819,000 924,434,000 155,776,000
Dec 2023 1,085,354,000 200,720,000 145,631,000 2,071,577,000 938,931,000 105,210,000
Dec 2022 983,680,000 192,431,000 142,849,000 1,659,698,000 663,788,000 103,312,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$0.83

Peers — same industry

TickerNameMarket CapLastDaily %
PRCT PROCEPT BioRobotics Corp $1.06B $18.62
DRTS Alpha Tau Medical Ltd. $1.06B $11.79
BVS Bioventus Inc. $892.24M $13.17
INMD InMode Ltd. $870.26M $15.14
IRMD IRADIMED CORP $1.16B $90.86

News headlines (Yahoo Finance, 1h cache)

Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries
2026-07-30 10:30 · Yahoo
Ionis Pharmaceuticals (IONS) Reports Q2 Loss, Tops Revenue Estimates
2026-07-29 12:25 · Yahoo
Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026
2026-07-21 10:30 · Yahoo
Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last?
2026-07-07 11:38 · Yahoo
TimesSquare Mid Cap Growth Strategy Downplays Market Fears on Stevanato Group S.p.A. (STVN)
2026-07-01 13:28 · Yahoo
Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?
2026-06-23 11:08 · Yahoo
Stevanato Group (STVN) Stock Valuation Check After Recent Share Price Weakness
2026-06-14 10:10 · Yahoo
Is Stevanato Group S.p.A. (STVN) A Good Stock To Buy Now?
2026-06-11 17:18 · Yahoo
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now
2026-06-09 15:05 · Yahoo
Implied Volatility Surging for Stevanato Stock Options
2026-06-03 15:50 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.